Mycophenolate in the prevention of recurrent neutralizing botulinum toxin A antibodies in cervical dystonia.
Identifieur interne : 003F99 ( PubMed/Corpus ); précédent : 003F98; suivant : 004000Mycophenolate in the prevention of recurrent neutralizing botulinum toxin A antibodies in cervical dystonia.
Auteurs : D D Duane ; J. Monroe ; R E MorrisSource :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2000.
English descriptors
- KwdEn :
- Antibody Formation (drug effects), Antibody Formation (immunology), Botulinum Toxins, Type A (administration & dosage), Botulinum Toxins, Type A (immunology), Humans, Immunosuppressive Agents (administration & dosage), Mycophenolic Acid (administration & dosage), Mycophenolic Acid (analogs & derivatives), Neutralization Tests, Premedication, Recurrence, Torticollis (drug therapy), Treatment Outcome.
- MESH :
- chemical , administration & dosage : Botulinum Toxins, Type A, Immunosuppressive Agents, Mycophenolic Acid.
- chemical , analogs & derivatives : Mycophenolic Acid.
- drug effects : Antibody Formation.
- drug therapy : Torticollis.
- immunology : Antibody Formation, Botulinum Toxins, Type A.
- Humans, Neutralization Tests, Premedication, Recurrence, Treatment Outcome.
PubMed: 10752603
Links to Exploration step
pubmed:10752603Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Mycophenolate in the prevention of recurrent neutralizing botulinum toxin A antibodies in cervical dystonia.</title>
<author><name sortKey="Duane, D D" sort="Duane, D D" uniqKey="Duane D" first="D D" last="Duane">D D Duane</name>
</author>
<author><name sortKey="Monroe, J" sort="Monroe, J" uniqKey="Monroe J" first="J" last="Monroe">J. Monroe</name>
</author>
<author><name sortKey="Morris, R E" sort="Morris, R E" uniqKey="Morris R" first="R E" last="Morris">R E Morris</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2000">2000</date>
<idno type="RBID">pubmed:10752603</idno>
<idno type="pmid">10752603</idno>
<idno type="wicri:Area/PubMed/Corpus">003F99</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Mycophenolate in the prevention of recurrent neutralizing botulinum toxin A antibodies in cervical dystonia.</title>
<author><name sortKey="Duane, D D" sort="Duane, D D" uniqKey="Duane D" first="D D" last="Duane">D D Duane</name>
</author>
<author><name sortKey="Monroe, J" sort="Monroe, J" uniqKey="Monroe J" first="J" last="Monroe">J. Monroe</name>
</author>
<author><name sortKey="Morris, R E" sort="Morris, R E" uniqKey="Morris R" first="R E" last="Morris">R E Morris</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2000" type="published">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibody Formation (drug effects)</term>
<term>Antibody Formation (immunology)</term>
<term>Botulinum Toxins, Type A (administration & dosage)</term>
<term>Botulinum Toxins, Type A (immunology)</term>
<term>Humans</term>
<term>Immunosuppressive Agents (administration & dosage)</term>
<term>Mycophenolic Acid (administration & dosage)</term>
<term>Mycophenolic Acid (analogs & derivatives)</term>
<term>Neutralization Tests</term>
<term>Premedication</term>
<term>Recurrence</term>
<term>Torticollis (drug therapy)</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Botulinum Toxins, Type A</term>
<term>Immunosuppressive Agents</term>
<term>Mycophenolic Acid</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Mycophenolic Acid</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Antibody Formation</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Torticollis</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Antibody Formation</term>
<term>Botulinum Toxins, Type A</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Neutralization Tests</term>
<term>Premedication</term>
<term>Recurrence</term>
<term>Treatment Outcome</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">10752603</PMID>
<DateCreated><Year>2000</Year>
<Month>06</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted><Year>2000</Year>
<Month>06</Month>
<Day>09</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0885-3185</ISSN>
<JournalIssue CitedMedium="Print"><Volume>15</Volume>
<Issue>2</Issue>
<PubDate><Year>2000</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Mycophenolate in the prevention of recurrent neutralizing botulinum toxin A antibodies in cervical dystonia.</ArticleTitle>
<Pagination><MedlinePgn>365-6</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duane</LastName>
<ForeName>D D</ForeName>
<Initials>DD</Initials>
</Author>
<Author ValidYN="Y"><LastName>Monroe</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Morris</LastName>
<ForeName>R E</ForeName>
<Initials>RE</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>UNITED STATES</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>9242ECW6R0</RegistryNumber>
<NameOfSubstance UI="C063008">mycophenolate mofetil</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.24.69</RegistryNumber>
<NameOfSubstance UI="D019274">Botulinum Toxins, Type A</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>HU9DX48N0T</RegistryNumber>
<NameOfSubstance UI="D009173">Mycophenolic Acid</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000917">Antibody Formation</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D019274">Botulinum Toxins, Type A</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration & dosage</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D007166">Immunosuppressive Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D009173">Mycophenolic Acid</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration & dosage</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000031">analogs & derivatives</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D009500">Neutralization Tests</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D011292">Premedication</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D012008">Recurrence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D014103">Torticollis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2000</Year>
<Month>4</Month>
<Day>7</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2000</Year>
<Month>6</Month>
<Day>17</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2000</Year>
<Month>4</Month>
<Day>7</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">10752603</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003F99 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 003F99 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:10752603 |texte= Mycophenolate in the prevention of recurrent neutralizing botulinum toxin A antibodies in cervical dystonia. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:10752603" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
![]() | This area was generated with Dilib version V0.6.23. | ![]() |